Yahoo! Finance: PLX News

Hospira Inks Deal with Genzyme (Zacks.com)

Tue, 5 Jan 2010 18:30:00 Etc/GMT

GENZ has entered into a contract manufacturing agreement with HSP for its key drugs, including Cerezyme and Fabrazyme.

PROTALIX BIOTHERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement (EDGAR Online)

Tue, 22 Dec 2009 21:31:10 Etc/GMT

FDA to issue decision on Shire's Gaucher drug (at MarketWatch)

Tue, 22 Dec 2009 14:36:18 Etc/GMT

3 Stocks in a Tailspin (at Motley Fool)

Thu, 17 Dec 2009 21:20:59 Etc/GMT

Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs (PR Newswire)

Thu, 17 Dec 2009 13:30:00 Etc/GMT

Protalix BioTherapeutics, Inc. today announced the appointment of Sandra Lauterbach to Vice President, Sales and Commercial Affairs. In this newly created, U.S. based position, Ms.

Protalix Drug Advances (Zacks.com)

Thu, 10 Dec 2009 20:50:59 Etc/GMT

The treatment for Gaucher disease has been granted orphan-drug designation and fast-track status by the FDA to facilitate its development.

PROTALIX BIOTHERAPEUTICS, INC. Files SEC form 8-K, Other Events (EDGAR Online)

Thu, 10 Dec 2009 11:00:54 Etc/GMT

Protalix Completes NDA Submission for taliglucerase alfa for the Treatment of Gaucher's Disease (Business Wire)

Wed, 9 Dec 2009 12:30:00 Etc/GMT

CARMIEL, Israel----Protalix Biotherapeutics, Inc. today announced the completion of its New Drug Application submission with the U.S. Food and Drug Administration for taliglucerase alfa, a plant-cell expressed form of glucocerebrosidase for the potential treatment of Gaucher’s disease.

Fearful Stocks for Greedy Investors (at Motley Fool)

Tue, 8 Dec 2009 19:11:02 Etc/GMT

Foreign Stocks You Can Actually Buy: Israel (at Motley Fool)

Mon, 7 Dec 2009 20:52:25 Etc/GMT

[video] Stocks Under $10: 2 Potential Buys (at TheStreet.com)

Sun, 6 Dec 2009 17:00:00 Etc/GMT

[video] Stocks Under $10: Two Buys (at TheStreet.com)

Sun, 6 Dec 2009 17:00:00 Etc/GMT

Skymark Research Initiates Independent Research Coverage on Protalix Biotherapeutics, Inc. (GlobeNewswire)

Fri, 4 Dec 2009 14:00:00 Etc/GMT

CALGARY, Alberta -- Skymark Research, a leading provider of small- and micro-cap independent investment research, today initiated coverage on Protalix Biotherapeutics, Inc. . Skymark Research is currently offering a complimentary trial subscription.

Genzyme Resumes Cerezyme Shipment (Zacks.com)

Thu, 3 Dec 2009 13:24:08 Etc/GMT

Above the Fray: 3 PowerRatings Stocks Passing the Test (TradingMarkets.com)

Thu, 3 Dec 2009 13:22:18 Etc/GMT

Active traders and investors know that it's just as difficult to pick winning short term stocks during bull markets as it is during bear markets. Here's a 3 step system to help you locate those shares ready to make short term gains in any market condition.

Stocks Under $10: 2 Potential Buys (TheStreet.com TV)

Wed, 2 Dec 2009 13:48:39 Etc/GMT

http://us.news2.yimg.com/us.yimg.com/p/fi/26/15/81.jpg/yfinance/tscm/strategysession/10635890http://www.thestreet.com/

[$$] Pfizer-Protalix Deal Bolsters Competition For Genzyme (at The Wall Street Journal Online)

Wed, 2 Dec 2009 00:55:07 Etc/GMT

Business Highlights (AP)

Tue, 1 Dec 2009 22:56:53 Etc/GMT

The economic recovery seems on track for slow but steady gains after new reports Tuesday showed growth in manufacturing activity, construction spending and contracts to buy homes.

Movers roundup: Bed Bath & Beyond (AP)

Tue, 1 Dec 2009 22:18:18 Etc/GMT

Shares of Bed Bath & Beyond rose after an analyst added the housewares retailer to its best ideas list and reiterated an "Outperform" rating.

Pfizer inks deal for new drugmaking technology (AP)

Tue, 1 Dec 2009 21:34:11 Etc/GMT

Pfizer Inc. will spend up to $115 million for rights to an Israeli biotech company's experimental drug and its promising technology for making that drug and others in carrot cells.